We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Campylobacter Rely on Pseudomonas to Infect Humans

By LabMedica International staff writers
Posted on 27 Oct 2010
The interaction between the different species of bacteria seems to be a mechanism for Campylobacter jejuni to remain viable and survive ambient oxygen levels. More...


C. jejuni is a microaerophilic gram-negative bacillus that causes febrile diarrhea or dysentery; vomiting or bloody stool are often noted with severe abdominal pain. The disease is most common among children and lasts one to four days.

Although Campylobacter infections are rarely life threatening, they are extremely debilitating and they have been linked with the development of Guillain-Barré syndrome, one of the leading causes of nontrauma-induced paralysis worldwide. The bacteria do not grow well at room temperature or in an oxygen-rich environment as it well adapted to life in the intestines of animals and humans. However, it is normally transmitted from contaminated chicken meat, as it is frequently found in the intestines of chickens, where it apparently does not result in any symptoms.

Scientists at the University of Veterinary Medicine (Vienna, Austria), have recently discovered that interactions with other bacteria allow C. jejuni to survive under hostile, oxygen-rich conditions. Campylobacter survived atmospheric oxygen levels for no longer than 18 hours when incubated alone or together with bacteria such as Proteus mirabilis, Citrobacter freundii, Micrococcus luteus or Enterococcus faecalis. However, when incubated together with various strains of Pseudomonas, Campylobacter were found to survive for much longer, in some cases over 48 hours, which would be easily long enough to cause infection. An in vitro assay was used to test the bacteria's survival rate.

There were differences in the extent of prolonged survival depending on the sources of the Campylobacter analyzed, but all isolates of all strains clearly survived significantly longer in the presence of Pseudomonas bacteria than when cultured alone. And the Campylobacter cells did not change shape when cultured together with Pseudomonas under oxygen-rich conditions, unlike when they were cultured alone, providing further indications of an interaction between the species. Interestingly, there is no evidence that the Pseudomonas benefit at all from the interaction, although they effectively facilitate the survival of Campylobacter under adverse conditions.

This microbial commensalism was diverse in C. jejuni isolates from different sources: isolates from chicken meat and humans in coculture with Ps. putida were able to use this survival support better than fecal isolates from broilers. Scanning electron microscopy revealed the development of fiber-like structures braiding Ps. putida and C. jejuni cells. Hence, it seems that microaerophilic C. jejuni is able to survive ambient atmospheric oxygen tension by metabolic commensalism with Pseudomonas species. This bacterial-bacterial interaction might set the basis for the survival of C. jejuni on chicken meat and thus be the prerequisite step in the pathway towards human infection. The study was published the October 2010 issue of Applied and Environmental Microbiology.

Related Links:
University of Veterinary Medicine




Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.